Search Results - "PISTILLI, Barbara"

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer by Rassy, Elie, Rached, Layal, Pistilli, Barbara

“…The identification of the HER2 alteration as an actionable oncogenic driver in breast cancer has propelled the development of HER-targeting monoclonal…”
Get full text

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial by Baselga, José, Prof, Im, Seock-Ah, Prof, Iwata, Hiroji, MD, Cortés, Javier, MD, De Laurentiis, Michele, MD, Jiang, Zefei, Prof, Arteaga, Carlos L, Prof, Jonat, Walter, Prof, Clemons, Mark, Prof, Ito, Yoshinori, MD, Awada, Ahmad, Prof, Chia, Stephen, MD, Jagiełło-Gruszfeld, Agnieszka, MD, Pistilli, Barbara, MD, Tseng, Ling-Ming, MD, Hurvitz, Sara, MD, Masuda, Norikazu, MD, Takahashi, Masato, MD, Vuylsteke, Peter, MD, Hachemi, Soulef, PhD, Dharan, Bharani, MS, Di Tomaso, Emmanuelle, PhD, Urban, Patrick, MD, Massacesi, Cristian, MD, Campone, Mario, Prof

“…Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast…”
Get full text

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis by Giuliano, Mario, MD, Schettini, Francesco, MD, Rognoni, Carla, PhD, Milani, Manuela, MD, Jerusalem, Guy, Prof, Bachelot, Thomas, MD, De Laurentiis, Michelino, MD, Thomas, Guglielmo, MD, De Placido, Pietro, MD, Arpino, Grazia, MD, De Placido, Sabino, Prof, Cristofanilli, Massimo, MD, Giordano, Antonio, MD, Puglisi, Fabio, MD, Pistilli, Barbara, MD, Prat, Aleix, MD, Del Mastro, Lucia, MD, Venturini, Sergio, PhD, Generali, Daniele, MD

“…SummaryBackgroundAlthough international guidelines support the administration of hormone therapies with or without targeted therapies in postmenopausal women…”
Get full text

Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study by AZIM, Hatem A, KROMAN, Niels, CORDOBA, Octavi, DE AZAMBUJA, Evandro, GOLDHIRSCH, Aron, PICCART, Martine J, PECCATORI, Fedro A, PAESMANS, Marianne, GELBER, Shari, ROTMENSZ, Nicole, AMEYE, Lieveke, DE MATTOS-ARRUDA, Leticia, PISTILLI, Barbara, PINTO, Alvaro, JENSEN, Maj-Britt

“…We questioned the impact of pregnancy on disease-free survival (DFS) in women with history of breast cancer (BC) according to estrogen receptor (ER) status. A…”
Get full text

Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study by Kaboré, Elisé G, Guenancia, Charles, Vaz-Luis, Ines, Di Meglio, Antonio, Pistilli, Barbara, Coutant, Charles, Cottu, Paul, Lesur, Anne, Petit, Thierry, Dalenc, Florence, Rouanet, Philippe, Arnaud, Antoine, Arsene, Olivier, Ibrahim, Mahmoud, Wassermann, Johanna, Boileau-Jolimoy, Geneviève, Martin, Anne-Laure, Lemonnier, Jérôme, André, Fabrice, Arveux, Patrick

“…In patients treated with cardiotoxic chemotherapies, the presence of cardiovascular risk factors and previous cardiac disease have been strongly correlated to…”
Get full text

Telehealth in breast cancer following the coronavirus disease 2019 pandemic by Zeghondy, Jean, Rassy, Elie, Lapidari, Pietro, Eid, Roland, Pistilli, Barbara

“…Breast cancer (BC) is the second most diagnosed cancer in 2018 with around 2.3 million cases globally in 2020. In March 2020 and after its worldwide spread,…”
Get full text

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? by Pagani, Olivia, Ruggeri, Monica, Manunta, Silvia, Saunders, Christobel, Peccatori, Fedro, Cardoso, Fatima, Kaufman, Bella, Paluch-Shimon, Shani, Gewefel, Hanan, Gallerani, Elisa, Abulkhair, OMalkahi, Pistilli, Barbara, Warner, Ellen, Saloustros, Emmanouil, Perey, Lucien, Zaman, Khalil, Rabaglio, Manuela, Gelber, Shari, Gelber, Richard D, Goldhirsch, Aron, Korde, Larissa, Azim, Hatem A, Partridge, Ann H

“…Abstract Young patients with breast cancer (BC) are often concerned about treatment-induced infertility and express maternity desire. Conception after BC does…”
Get full text

Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort by Frank, Sophie, Carton, Matthieu, Dubot, Coraline, Campone, Mario, Pistilli, Barbara, Dalenc, Florence, Mailliez, Audrey, Levy, Christelle, D’Hondt, Véronique, Debled, Marc, Vermeulin, Thomas, Coudert, Bruno, Perrin, Christophe, Gonçalves, Anthony, Uwer, Lionel, Ferrero, Jean-Marc, Eymard, Jean-Christophe, Petit, Thierry, Mouret-Reynier, Marie-Ange, Patsouris, Anne, Guesmia, Tahar, Bachelot, Thomas, Robain, Mathieu, Cottu, Paul

“…Young age is a poor prognostic factor in early stage breast cancer (BC) but its value is less established in metastatic BC (MBC). We evaluated the impact of…”
Get full text

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer by Chan, Arlene, Ruiz-Borrego, Manuel, Marx, Gavin, Chien, A. Jo, Rugo, Hope S., Brufsky, Adam, Thirlwell, Michael, Trudeau, Maureen, Bose, Ron, García-Sáenz, José A., Egle, Daniel, Pistilli, Barbara, Wassermann, Johanna, Cheong, Kerry A., Schnappauf, Benjamin, Semsek, Dieter, Singer, Christian F., Foruzan, Navid, DiPrimeo, Daniel, McCulloch, Leanne, Hurvitz, Sara A., Barcenas, Carlos H.

“…Neratinib is an irreversible pan-HER tyrosine kinase inhibitor approved for HER2-positive early-stage and metastatic breast cancer. Diarrhea is the most…”
Get full text

Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial by Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Pierga, Jean-Yves, Canon, Jean-Luc, Clatot, Florian, Andre, Fabrice, De La Motte Rouge, Thibault, Pistilli, Barbara, Dalenc, Florence, Dohollou, Nadine, Arsene, Olivier, Petit, Thierry, Riedl, Cécilia, Morvan, François, Marti, Adina, Lachaier, Emma, Achille, Mihaela, Gozy, Michel, Escande, Anne, Mille, Dominique, Trouboul, Fanny, Arnould, Laurent, Bieche, Ivan, Pradines, Anne, Lemonnier, Jerome, Berger, Frederique, Delaloge, Suzette

“…Background: ESR1 mutations are known drivers of resistance to first line aromatase inhibitors (AI)-based therapy in hormone receptor-positive (HR+) HER2-…”
Get full text

Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence by Finicelli, Mauro, Benedetti, Giovanni, Squillaro, Tiziana, Pistilli, Barbara, Marcellusi, Andrea, Mariani, Paola, Santinelli, Alfredo, Latini, Luciano, Galderisi, Umberto, Giordano, Antonio

“…The events leading to breast cancer (BC) progression or recurrence are not completely understood and new prognostic markers aiming at identifying high…”
Get full text

A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design by Di Meglio, Antonio, Martin, Elise, Crane, Tracy E, Charles, Cecile, Barbier, Aude, Raynard, Bruno, Mangin, Anthony, Tredan, Olivier, Bouleuc, Carole, Cottu, Paul H, Vanlemmens, Laurence, Segura-Djezzar, Carine, Lesur, Anne, Pistilli, Barbara, Joly, Florence, Ginsbourger, Thomas, Coquet, Bernadette, Pauporte, Iris, Jacob, Guillemette, Sirven, Aude, Bonastre, Julia, Ligibel, Jennifer A, Michiels, Stefan, Vaz-Luis, Ines

“…Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors,…”
Get full text

Intracranial hypotension in a breast cancer patient treated with epidural blood patches by Minot-This, Marie-Sophie, Grinda, Thomas, Epaillard, Nicolas, Guyon, David, Jawiche, Rita El, Garcia, Gabriel, Pistilli, Barbara

“…We report the case of a patient with metastatic breast cancer who presented with an orthostatic headache. After a comprehensive diagnostic workup including…”
Get full text

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer by Lapidari, Pietro, Gbenou, Arnauld, Havas, Julie, Martin, Elise, Pistilli, Barbara, Martin, Anne-Laure, Everhard, Sibille, Coutant, Charles, Cottu, Paul, Lesur, Anne, Lerebours, Florence, Tredan, Olivier, Vanlemmens, Laurence, Jouannaud, Christelle, Levy, Christelle, Rigal, Olivier, Fournier, Marion, Andre, Fabrice, Vaz-Luis, Ines, Di Meglio, Antonio

“…We assessed long-term associations of Granulocyte-Colony Stimulating Factors (G-CSF) use with patient-reported outcomes (PROs) and hematologic toxicity among…”
Get full text

Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools by Rassy, Elie, Benvenuti, Chiara, Akla, Sarra, Di Meglio, Antonio, Martin, Elise, Havas, Julie, Rieutord, André, Combarel, David, Fasse, Léonor, Scotté, Florian, Guéroult Accolas, Laure, Jacob, Guillemette, Bergougnoux, Anne, Delaloge, Suzette, Vaz-Luis, Ines, Pistilli, Barbara

“…Understanding breast cancer survivors’ perspectives is critical to personalizing endocrine therapy (ET) in the adjuvant setting. A nationwide survey among…”
Get full text

Sustainable return to work among breast cancer survivors by Ruiz de Azua, Garazi, Kousignian, Isabelle, Vaz‐Luis, Ines, Di Meglio, Antonio, Caumette, Elsa, Havas, Julie, Martin, Elise, Martin, Anne‐Laure, Querel, Ophelie, Vanlemmens, Laurence, Pistilli, Barbara, Coutant, Charles, Cottu, Paul Henri, Merimeche, Asma Dhaini, Lerebours, Florence, Tredan, Olivier, Jouannaud, Christelle, Levy, Christelle, Dumas, Agnes, Menvielle, Gwenn

“…Purpose This study assessed sustainable return to work (SRTW) of breast cancer survivors (BCS). Methods We used data from the prospective French cohort, CANTO…”
Get full text

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program by Cabel, Luc, Carton, Matthieu, Pistilli, Barbara, Dalenc, Florence, Vanlemnens, Laurence, Levy, Christelle, Jacot, William, Debled, Michel, Loeb, Agnes, Hennequin, Audrey, De la Motte Rouge, Thibault, Laborde, Lilian, Laurent, Carine, Chamorey, E., Parent, Damien, Petit, Thierry, Mouret-Reynier, Marie-Ange, Campone, Mario, Perrocheau, Geneviève, Labreveux, Claire, Bachelot, Thomas, Robain, Mathieu, Lerebours, Florence

“…Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of…”
Get full text

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? by Pistilli, Barbara, Bellettini, Giulia, Giovannetti, Elisa, Codacci-Pisanelli, Giovanni, Azim, Hatem A, Benedetti, Giovanni, Sarno, Maria Anna, Peccatori, Fedro A

“…Abstract An increasing number of women are diagnosed with cancer during pregnancy and lactation. Women are usually advised to interrupt breastfeeding during…”
Get full text

Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2 by Beck, J. Thaddeus, Hortobagyi, Gabriel N., Campone, Mario, Lebrun, Fabienne, Deleu, Ines, Rugo, Hope S., Pistilli, Barbara, Masuda, Norikazu, Hart, Lowell, Melichar, Bohuslav, Dakhil, Shaker, Geberth, Matthias, Nunzi, Martina, Heng, Daniel Y. C., Brechenmacher, Thomas, El-Hashimy, Mona, Douma, Shyanne, Ringeisen, Francois, Piccart, Martine

Get full text

Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME) by Sirieix, Junien, Fraisse, Julien, Mathoulin-Pelissier, Simone, Leheurteur, Marianne, Vanlemmens, Laurence, Jouannaud, Christelle, Diéras, Véronique, Lévy, Christelle, Ung, Mony, Mouret-Reynier, Marie-Ange, Petit, Thierry, Coudert, Bruno, Brain, Etienne, Pistilli, Barbara, Ferrero, Jean-Marc, Goncalves, Anthony, Uwer, Lionel, Patsouris, Anne, Tredan, Olivier, Courtinard, Coralie, Gourgou, Sophie, Frénel, Jean-Sébastien

“…Background and Aims: Because of its low prevalence, metastatic breast cancer (MBC) in males is managed based on clinical experience with women. Using a…”
Get full text